Trials / Unknown
UnknownNCT01843985
Observational Study of Survival Outcomes of Stage IV Cancer Patients
Observational Study of Survival Times of Stage IV Cancer Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Cure Cancer Worldwide Corporation · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Patients diagnosed with Stage IV cancer (solid tumors only) are evaluated to determine whether they are candidates for traditional chemotherapy. If eligible, patients are offered traditional chemotherapy, low-dose chemotherapy, or palliative care. If ineligible, patients are offered low-dose chemotherapy or palliative care. Patients will be monitored for 5 years and survival data recorded.
Conditions
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2013-05-01
- Last updated
- 2013-05-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01843985. Inclusion in this directory is not an endorsement.